Anti-CGRP agent delivered durable episodic migraine prevention

VANCOUVER – An investigational antibody that targets the calcitonin gene-related peptide (CGRP) receptor may be efficacious and safe in the longer term for preventing episodic migraine, data from an...
Source: Clinical Neurology News - Category: Neurology Source Type: news